Covid vaccine deaths review sent to top of FDA, but with far less certain conclusions, sources say
消息称：关于新冠疫苗死亡的审查已递交至美国FDA高层，但结论远不那么确定

An FDA staff analysis of the safety of pediatric Covid-19 shots has been finalized and sent to the agency’s vaccine and biologics head Vinay Prasad. But the report comes to many fewer firm conclusions than two of the agency’s biggest critics of the vaccines have suggested it would.
美国食品药品监督管理局(FDA)工作人员对儿童新冠疫苗安全性的分析已定稿，并已送交该机构疫苗与生物制品负责人维奈•普拉萨德。但这份报告得出的明确结论远少于该机构两位最严厉疫苗批评者此前所暗示的程度。